Publication | Closed Access

Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial

UrologyAbiraterone AcetateMedicinePharmacologyClinical TrialsEarly-access Protocol TrialPharmacotherapyCancer TreatmentProstatic DiseaseOncologyFinal Analysis